Trial Profile
A Randomized, Controlled Trial to Compare Protection in Adolescents Between Different Meningococcal Immunization Schedules Used in Canada; a Canadian Immunization Research Network (CIRN) Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2022
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Therapeutic Use
- 10 Mar 2022 Status changed from active, no longer recruiting to completed.
- 02 Sep 2020 Planned End Date changed from 1 Mar 2021 to 1 Aug 2021.
- 02 Sep 2020 Planned primary completion date changed from 1 Dec 2020 to 1 Aug 2021.